A Casonato
Overview
Explore the profile of A Casonato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taverna B, Casonato A, Bezzo F, Galvanin F
Comput Methods Programs Biomed
. 2019 Aug;
179:104989.
PMID: 31443861
Background And Objective: Von Willebrand disease (VWD) is one of the most severe inherited bleeding disorder in humans, and it is associated with a qualitative and/or quantitative deficiency of von...
2.
Casonato A, Galletta E, Sarolo L, Daidone V
Haemophilia
. 2017 Nov;
24(1):134-140.
PMID: 29115006
Introduction: An abnormal factor VIII (FVIII) binding capacity of von Willebrand factor (VWF) identifies type 2N von Willebrand disease (VWD). Type 2N VWD patients are identified by means of the...
3.
Daidone V, Barbon G, Cattini M, Pontara E, Romualdi C, Di Pasquale I, et al.
Haemophilia
. 2016 Jun;
22(6):949-956.
PMID: 27293213
Introduction: The heterogeneity of von Willebrand disease (VWD) makes its diagnosis a difficult task. Methods: We report here on the usefulness of a microchip-based flow-chamber system, the total thrombus-formation analysis...
4.
Casonato A, Cattini M, Barbon G, Daidone V, Pontara E
Thromb Res
. 2015 Aug;
136(3):682-6.
PMID: 26251079
Bullet Points: What is known about this topic? - Type 1 VWD is transmitted mainly as a dominant trait. - Recessive type 1 mutations at homozygous or compound heterozygous level...
5.
Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor
Daidone V, Barbon G, Pontara E, Cattini G, Gallinaro L, Zampese E, et al.
Thromb Haemost
. 2014 Sep;
112(6):1159-66.
PMID: 25230768
Cysteines play a key part in von Willebrand factor (VWF) dimerisation and polymerisation, and their loss may severely affect VWF structure and function. We report on three patients with type...
6.
Koutroumpi S, Daidone V, Sartori M, Cattini M, Albiger N, Occhi G, et al.
Pituitary
. 2012 May;
16(2):175-81.
PMID: 22585010
A high incidence of venous thromboembolic (VTE) complications has been reported in Cushing's syndrome (CS), mostly post-operatively and attributable to hypercoagulability. The prevalence of symptomatic VTE was investigated retrospectively in...
7.
Gallinaro L, Casonato A, Vianello F, Fadin M, Cella G
Haemophilia
. 2009 Jun;
15(5):1171-3.
PMID: 19558489
No abstract available.
8.
Sztukowska M, Gallinaro L, Cattini M, Pontara E, Sartorello F, Daidone V, et al.
Br J Haematol
. 2008 Aug;
143(1):107-14.
PMID: 18691167
Reduced von Willebrand factor (VWF) half-life has been suggested as a new pathogenic mechanism in von Willebrand disease (VWD). The usefulness of VWF propeptide (VWFpp) in exploring VWF half-life was...
9.
Casonato A, Pontara E, Sartorello F, Cattini M, Perutelli P, Bertomoro A, et al.
Clin Appl Thromb Hemost
. 2007 Apr;
13(2):194-200.
PMID: 17456630
The defective FVIII carrier function of von Willebrand factor (VWF) identifies type 2N von Willebrand disease (VWD), a variant with a pattern resembling hemophilia A. Type 2N characterization is based...
10.
Casonato A, Fabris F, Pontara E, Cattini M, Zocca N, Gallinaro L, et al.
Clin Appl Thromb Hemost
. 2006 Sep;
12(3):296-304.
PMID: 16959682
Thrombotic thrombocytopenic purpura (TTP) is characterized by intravascular thrombosis leading to consumption of large or unusually large von Willebrand factor (VWF) multimers. The usefulness of VWF collagen binding (VWF:CB) assay...